Next Article in Journal
Leptin levels at birth and in early postnatal life in small- and appropriate-for-gestational-age infants
Previous Article in Journal
Relationship between isolation of extended spectrum beta-lactamase-producing Klebsiella pneumoniae and course of hospital-acquired pneumonia
Article Menu
Issue 3 (July) cover image

Export Article

Open AccessReview
Medicina 2018, 54(3), 47; https://doi.org/10.3390/medicina54030047

Positron Emission Tomography in the Diagnosis and Management of Coronary Artery Disease

1
Department of Cardiology, Medical Academy, Lithuanian University of Health Sciences, Kaunas LT-50161, Lithuania
2
Department of Radiology, Medical Academy, Lithuanian University of Health Sciences, Kaunas LT-50161, Lithuania
*
Author to whom correspondence should be addressed.
Received: 18 June 2018 / Accepted: 3 July 2018 / Published: 11 July 2018
Full-Text   |   PDF [1641 KB, uploaded 11 July 2018]   |  

Abstract

Cardiac positron emission tomography (PET) and positron emission tomography/computed tomography (PET/CT) are encouraging precise non-invasive imaging modalities that allow imaging of the cellular function of the heart, while other non-invasive cardiovascular imaging modalities are considered to be techniques for imaging the anatomy, morphology, structure, function and tissue characteristics. The role of cardiac PET has been growing rapidly and providing high diagnostic accuracy of coronary artery disease (CAD). Clinical cardiology has established PET as a criterion for the assessment of myocardial viability and is recommended for the proper management of reduced left ventricle (LV) function and ischemic cardiomyopathy. Hybrid PET/CT imaging has enabled simultaneous integration of the coronary anatomy with myocardial perfusion and metabolism and has improved characterization of dysfunctional areas in chronic CAD. Also, the availability of quantitative myocardial blood flow (MBF) evaluation with various PET perfusion tracers provides additional prognostic information and enhances the diagnostic performance of nuclear imaging. View Full-Text
Keywords: positron emission tomography; coronary artery disease; myocardial viability; myocardial perfusion imaging positron emission tomography; coronary artery disease; myocardial viability; myocardial perfusion imaging
Figures

Figure 1

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited (CC BY 4.0).
SciFeed

Share & Cite This Article

MDPI and ACS Style

Kazakauskaitė, E.; Žaliaduonytė-Pekšienė, D.; Rumbinaitė, E.; Keršulis, J.; Kulakienė, I.; Jurkevičius, R. Positron Emission Tomography in the Diagnosis and Management of Coronary Artery Disease. Medicina 2018, 54, 47.

Show more citation formats Show less citations formats

Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Metrics

Article Access Statistics

1

Comments

[Return to top]
Medicina EISSN 1010-660X Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top